Back to company

BIOSYNTIA ApS: Financial statements 2014

CVR: 34892970

BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 1,577,651 and a net result of DKK -3,885 compared with DKK -27,777 the year before. That is an increase of 305.5% compared with the year before. Equity amounted to DKK 48,338. The solvency ratio was 1.2%.

Gross Profit
1,577,651 kr.
Profit/Loss
-3,885 kr.
Equity
48,338 kr.
Total Assets
3,894,979 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-1.6 mio.-4 t.48 t.-
2013-389 t.-28 t.52 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on BIOSYNTIA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

Hans Jasper Genee joins the board of BIOSYNTIA ApSMay 13, 2014

As of May 13, 2014, Hans Jasper Genee has joined the board of directors of BIOSYNTIA ApS.

Henrik Dalbøge joins the board of BIOSYNTIA ApSMay 13, 2014

As of May 13, 2014, Henrik Dalbøge has joined the board of directors of BIOSYNTIA ApS.

Morten Otto Alexander Sommer joins the board of BIOSYNTIA ApSMay 13, 2014

As of May 13, 2014, Morten Otto Alexander Sommer has joined the board of directors of BIOSYNTIA ApS.

Hans Jasper Genee joins BIOSYNTIA ApS as adm. dir.May 13, 2014

As of May 13, 2014, Hans Jasper Genee is registered as adm. dir. of BIOSYNTIA ApS.

Morten Otto Alexander Sommer steps down as director of BIOSYNTIA ApSMay 13, 2014

As of May 13, 2014, Morten Otto Alexander Sommer has stepped down as director of BIOSYNTIA ApS.

BIOSYNTIA ApS: The 2013 annual report is outMay 12, 2014

BIOSYNTIA ApS has published its annual report for 2013. Gross profit came to DKK 389,094, and the net result was DKK -27,777.

About BIOSYNTIA ApS

BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees. In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity amounted to DKK 32,860,576.